Róisín Adams

660 total citations
28 papers, 387 citations indexed

About

Róisín Adams is a scholar working on Economics and Econometrics, General Health Professions and Epidemiology. According to data from OpenAlex, Róisín Adams has authored 28 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Economics and Econometrics, 7 papers in General Health Professions and 6 papers in Epidemiology. Recurrent topics in Róisín Adams's work include Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (6 papers) and Global Health Care Issues (3 papers). Róisín Adams is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (15 papers), Pharmaceutical Economics and Policy (6 papers) and Global Health Care Issues (3 papers). Róisín Adams collaborates with scholars based in Ireland, Netherlands and United Kingdom. Róisín Adams's co-authors include Cathal Walsh, Susanne Schmitz, Michael Barry, Oliver FitzGerald, Barry Bresnihan, Douglas J. Veale, Laura McCullagh, Niall Tubridy, Christopher McGuigan and David J. McConnell and has published in prestigious journals such as Scientific Reports, Annals of the Rheumatic Diseases and Statistics in Medicine.

In The Last Decade

Róisín Adams

28 papers receiving 379 citations

Peers

Róisín Adams

RHEUM

EPIDE

IMMUN

Devin Incerti United States

Eleanor M. Pinto United Kingdom

Jean‐David Zeitoun France

Nicholas Adlard Switzerland

Jammbe Musoro Belgium

Thierry Lobbedez France

Ruth Schwarzer United States

Henk J. Out Netherlands

Samuel U Takvorian United States

Rohan Parikh United States

Devin Incerti United States

Róisín Adams

77 ×0.6

31 ×0.3

RHEUM

58 ×1.0

EPIDE

60 ×1.1

IMMUN

33 ×0.6

Citations per year, relative to Róisín Adams Róisín Adams (= 1×) peers Devin Incerti

Countries citing papers authored by Róisín Adams

Since Specialization

Citations

This map shows the geographic impact of Róisín Adams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Róisín Adams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Róisín Adams more than expected).

Fields of papers citing papers by Róisín Adams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Róisín Adams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Róisín Adams. The network helps show where Róisín Adams may publish in the future.

Co-authorship network of co-authors of Róisín Adams

This figure shows the co-authorship network connecting the top 25 collaborators of Róisín Adams. A scholar is included among the top collaborators of Róisín Adams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Róisín Adams. Róisín Adams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Adams, Róisín, et al.. (2024). Advancing cooperation in Health Technology Assessment in Europe: insights from the EUnetHTA 21 project amidst the evolving legal landscape of European HTA. International Journal of Technology Assessment in Health Care. 40(1). e75–e75. 4 indexed citations

Vreman, Rick A., et al.. (2023). The Beneluxa Initiative domain task force health technology assessment: a comparison of member countries’ past health technology assessments. International Journal of Technology Assessment in Health Care. 39(1). e44–e44. 2 indexed citations

McConnell, David J., Cathal Walsh, Desmond M. Murphy, et al.. (2022). Comparative effectiveness of neutralising monoclonal antibodies in high risk COVID-19 patients: a Bayesian network meta-analysis. Scientific Reports. 12(1). 17561–17561. 4 indexed citations

Eichler, Hans‐Georg, Róisín Adams, Peter Arlett, et al.. (2021). Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements. International Journal of Technology Assessment in Health Care. 37(1). e83–e83. 15 indexed citations

Kennedy, Cormac, et al.. (2021). Estimating the Theoretical Cost Implications of Funding New Drugs Considered Not to Be Cost-Effective. Value in Health. 24(10). 1402–1406. 1 indexed citations

Schmitz, Susanne, Tatjana T. Makovski, Róisín Adams, et al.. (2019). Bayesian Hierarchical Models for Meta-Analysis of Quality-of-Life Outcomes: An Application in Multimorbidity. PharmacoEconomics. 38(1). 85–95. 1 indexed citations

Schmitz, Susanne, Laura McCullagh, Róisín Adams, Michael Barry, & Cathal Walsh. (2016). Identifying and Revealing the Importance of Decision-Making Criteria for Health Technology Assessment: A Retrospective Analysis of Reimbursement Recommendations in Ireland. PharmacoEconomics. 34(9). 925–937. 21 indexed citations

Usher, Cara, Róisín Adams, Susanne Schmitz, et al.. (2016). Evaluating the neonatal BCG vaccination programme in Ireland. Archives of Public Health. 74(1). 28–28. 7 indexed citations

Mar, Javier, et al.. (2016). Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients. Expert Review of Gastroenterology & Hepatology. 11(1). 85–93. 13 indexed citations

10.

Walsh, Cathal, et al.. (2015). Results of the Eq-5d-3l Valuation Project for Ireland. Value in Health. 18(7). A740–A740. 1 indexed citations

11.

Walsh, Cathal, et al.. (2015). Experienced Vs. Hypothetical Health States Preferences Using Eq-5d 3l And 5l Versions: A National Study. Value in Health. 18(7). A741–A741. 1 indexed citations

12.

Adams, Róisín, et al.. (2015). Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data. Value in Health. 18(6). 841–845. 2 indexed citations

13.

McCullagh, Laura, et al.. (2014). HTA Informed Price Negotiations: Cost Savings To The Health Payer in Ireland. Value in Health. 17(7). A420–A420. 1 indexed citations

14.

Usher, Cara, Róisín Adams, Cathal Walsh, et al.. (2013). Paediatric Tuberculosis - Costs to the Irish Health Care Payer. Value in Health. 16(7). A370–A370. 1 indexed citations

15.

Schmitz, Susanne, et al.. (2013). Meta-analysis of BCG Vaccine Efficacy for Infants in Ireland. Value in Health. 16(7). A331–A331. 1 indexed citations

16.

Schmitz, Susanne, Róisín Adams, & Cathal Walsh. (2012). The use of continuous data versus binary data in MTC models: A case study in rheumatoid arthritis. BMC Medical Research Methodology. 12(1). 167–167. 24 indexed citations

17.

Adams, Róisín, Benjamin M. Craig, Cathal Walsh, et al.. (2011). The Impact of a Revised EQ-5D Population Scoring on Preference-Based Utility Scores in an Inflammatory Arthritis Cohort. Value in Health. 14(6). 921–927. 6 indexed citations

18.

Schmitz, Susanne, Róisín Adams, Cathal Walsh, Michael Barry, & Oliver FitzGerald. (2011). A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach. Annals of the Rheumatic Diseases. 71(2). 225–230. 63 indexed citations

19.

Adams, Róisín, Cathal Walsh, Douglas J. Veale, et al.. (2010). Understanding the Relationship between the EQ-5D, SF-6D, HAQ and Disease Activity in Inflammatory Arthritis. PharmacoEconomics. 28(6). 477–487. 39 indexed citations

20.

Louw, Julia, et al.. (2007). Exploring the challenges of HIV/AIDS: seminar proceedings. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact